ARTG 390437Axonics Neurostimulator - Stimulator, electrical, neuromuscular, incontinence, implantable
ARTG ID: 390437 · Axonics Modulation Technologies Australia Pty Ltd · Axonics Inc · Class III · Started June 15, 2022
Good Name: Axonics Modulation Technologies Australia Pty Ltd - Axonics Neurostimulator - Stimulator, electrical, neuromuscular, incontinence, implantable
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 390437
- Start Date
- June 15, 2022
- Effective Date
- June 15, 2022
- Name
- Axonics Inc
- Country
- United States of America
- Address
- 26 Technology Drive, Irvine, California, 92618
The neurostimulator is an implantable device intended to treat urinary and/or faecal incontinence.
Access comprehensive regulatory information for Axonics Neurostimulator - Stimulator, electrical, neuromuscular, incontinence, implantable in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 390437 and sponsored by Axonics Modulation Technologies Australia Pty Ltd, manufactured by Axonics Inc in United States of America. The device registration started on June 15, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.